Massachusetts H5385 establishes Medicaid coverage for rapid whole genome sequencing for eligible beneficiaries.

Massachusetts H5385 mandates the Executive Office of Health and Human Services to implement Medicaid coverage for rapid whole genome sequencing. This coverage applies to beneficiaries aged 21 and under with complex or acute illnesses of unknown etiology, receiving inpatient hospital services. The sequencing must return preliminary results within 5 days and final results within 14 days. The Division of Medical Assistance will establish a separate reimbursement rate for this service. The act also requires notification to hospitals within 12 months of regulatory promulgation.

Massachusetts H5385 establishes Medicaid coverage for rapid whole genome sequencing for eligible beneficiaries.

Massachusetts H5385 mandates the Executive Office of Health and Human Services to implement Medicaid coverage for rapid whole genome sequencing. This coverage applies to beneficiaries aged 21 and under with complex or acute illnesses of unknown etiology, receiving inpatient hospital services. The sequencing must return preliminary results within 5 days and final results within 14 days. The Division of Medical Assistance will establish a separate reimbursement rate for this service. The act also requires notification to hospitals within 12 months of regulatory promulgation.